Following Outcomes Remotely Within Addiction Recovery Domains

CTN-0126 Following Outcomes Remotely Within Addiction Recovery Domains

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06001437

Acronym

FORWARD

Enrollment

369

Registered

2023-08-21

Start date

2023-09-02

Completion date

2026-06-30

Last updated

2026-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Opioid Use Disorder

Brief summary

The aim of this study is to describe outcome of people with opioid use disorder over the long-term by collecting monthly and yearly data on their recovery. Adults with opioid use disorder who participate will complete surveys monthly online and once per year by phone about their substance use, mental health, treatment involvement and functioning. The goal of this study is to better understand how people with opioid use disorder recover over time to improve intervention for this group.

Detailed description

This is a longitudinal follow-up study that will collect yearly outcomes data on adults with opioid use disorder (OUD) who participated one of two prior clinical trials in the NIDA Clinical Trials Network. This longitudinal, observational study will entail annual phone and online assessments of domains of interest (e.g., substance use, treatment engagement) as well as monthly assessments that are distributed via text messaging and email to be completed electronically by the participant. No participant randomization will occur for this study, and study data will be considered observational in nature. We aim to characterize the long-term course of OUD and to evaluate the long-term course and recovery of OUD.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Inclusion criteria

1. Be an enrolled participant in one of two applicable clinical trials and be no longer than 24 months after the final expected assessment for that trial. 2. Be willing and able to provide locator information for survey distribution (mobile number and/or email address). 3. Be willing to allow the linkage of prior clinical trial study data to the current study record.

Exclusion criteria

1. Unable to understand or communicate to complete consent or study assessments. 2. Are currently in jail, prison or other overnight facility as required by court of law or have pending legal action that could prevent participation in study activities. 3. Other factors that would cause harm or increased risk to the participant or close contacts or preclude the participant's full adherence with or completion of the study.

Design outcomes

Primary

Measure	Time frame	Description
Opioid Use	12 months	Count of months of opioid use.
Engagement in Treatment	12 months	Count of months engaged in treatment for opioid use disorder

Countries

United States

Outcome results